文献速递骨质疏松与钙磷/甲状旁腺

骨微结构可独立预测老年人群骨折风险:BoMIC前瞻性研究

Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2018-11-28

BACKGROUND: Although areal bone mineral density (aBMD) assessed by dual-energy x-ray absorptiometry (DXA) is the clinical standard for determining fracture risk, most older adults who sustain a fracture have T scores greater than -2·5 and thus do not meet the clinical criteria fo…

要点

  • HR-pQCT骨微结构指标与骨折风险独立相关,可补充aBMD和FRAX的预测价值。

核心结论

  • HR-pQCT骨微结构指标和失效载荷可在股骨颈aBMD或FRAX评分之外改善骨折预测。
  • 骨小梁和骨皮质密度与结构的缺陷独立贡献于骨折风险。

研究设计与样本

  • 前瞻性研究,纳入来自美国、法国、瑞士、加拿大和瑞典8个队列的7254名个体(66%女性,34%男性)。
  • 采用Cox比例风险模型估计HR-pQCT骨指标与骨折风险的关联,逐步调整年龄、性别、身高、体重、队列、股骨颈aBMD或FRAX评分。

主要发现

  • 进一步调整股骨颈aBMD或FRAX评分后,关联减弱但多数骨参数仍显著。
  • 包含桡骨远端皮质体积骨密度、骨小梁数目和骨小梁厚度的模型,以及胫骨上述指标加皮质面积的模型,是骨折的最佳预测模型。

临床怎么用

  • 在临床骨折风险评估中,可考虑HR-pQCT骨微结构测量以识别aBMD或FRAX未覆盖的高风险个体。
  • 关注外周骨失效载荷、皮质孔隙率及骨小梁密度与结构等指标,辅助判断骨折风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although areal bone mineral density (aBMD) assessed by dual-energy x-ray absorptiometry (DXA) is the clinical standard for determining fracture risk, most older adults who sustain a fracture have T scores greater than -2·5 and thus do not meet the clinical criteria for osteoporosis. Importantly, bone fragility is due to low BMD and deterioration in bone structure. We assessed whether indices of high-resolution peripheral quantitative CT (HR-pQCT) were associated with fracture risk independently of femoral neck aBMD and the Fracture Risk Assessment Tool (FRAX) score. METHODS: We assessed participants in eight cohorts from the USA (Framingham, Mayo Clinic), France (QUALYOR, STRAMBO, OFELY), Switzerland (GERICO), Canada (CaMos), and Sweden (MrOS). We used Cox proportional hazard ratios (HRs) to estimate the association between HR-pQCT bone indices (per 1 SD of deficit) and incident fracture, adjusting for age, sex, height, weight, and cohort, and then additionally for femoral neck DXA aBMD or FRAX. FINDINGS: 7254 individuals (66% women and 34% men) were assessed. Mean baseline age was 69 years (SD 9, range 40-96). Over a mean follow-up of 4·63 years (SD 2·41) years, 765 (11%) participants had incident fractures, of whom 633 (86%) had femoral neck T scores greater than -2·5. After adjustment for age, sex, cohort, height, and weight, peripheral skeleton failure load had the greatest association with risk of fracture: tibia HR 2·40 (95% CI 1·98-2·91) and radius 2·13 (1·77-2·56) per 1 SD decrease. HRs for other bone indices ranged from 1·12 (95% CI 1·03-1·23) per 1 SD increase in tibia cortical porosity to 1·58 (1·45-1·72) per 1 SD decrease in radius trabecular volumetric bone density. After further adjustment for femoral neck aBMD or FRAX score, the associations were reduced but remained significant for most bone parameters. A model including cortical volumetric bone density, trabecular number, and trabecular thickness at the distal radius and a model including these indices plus cortical area at the tibia were the best predictors of fracture. INTERPRETATION: HR-pQCT indices and failure load improved prediction of fracture beyond femoral neck aBMD or FRAX scores alone. Our findings from a large international cohort of men and women support previous reports that deficits in trabecular and cortical bone density and structure independently contribute to fracture risk. These measurements and morphological assessment of the peripheral skeleton might improve identification of people at the highest risk of fracture. FUNDING: National Institutes of Health National Institute of Arthritis Musculoskeletal and Skin Diseases.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Samelson EJ, Broe KE, Xu H, et al. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. 2018. PMID: 30503163. doi:10.1016/S2213-8587(18)30308-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。